Sofia Angels Ventures – New Investment Press Release
In September 2023 Sofia Angels Ventures (SAV), a €13M venture fund backed up by EIF for angel and private co-investment, headquartered in Sofia, announced its tenth investment – inHEART – a groundbreaking digital health startup that is revolutionizing prevention and treatment of cardiac arrhythmias.
inHEART, a spin-off of the IHU Liryc in Bordeaux, France and Inria Sophia-Antipolis, was incorporated in July 2017 and has since made significant strides in transforming the landscape of cardiac care. The company is leveraging artificial intelligence (AI) segmentation to develop cutting-edge software for 3D modelling of the heart. The inHEART solution aids in planning and guiding catheter ablations for patients with cardiac arrhythmias and helps cardiologists protect their patients from developing complications.
Cardiac arrhythmias affect millions of individuals worldwide, with more than 800,000 individuals dying from cardiac arrhythmias in the US and Europe every year, necessitating innovative solutions to improve treatment outcomes and patient experiences. inHEART’s revolutionary, digital twin of the heart has emerged as a game-changer, bringing immense benefits to the entire healthcare ecosystem. The integration of AI-segmentation in the 3D modelling process has not only halved the procedure time but also led to a remarkable 25% increase in the success rate of catheter ablations.
SAV’s investment of EUR 500,000 is part of inHEART’s EUR 5,800,000 funding round, led by the renowned healthcare fund, Elaia. With this funding, inHEART aims to further enhance its technology, accelerate its commercial progress across EU and US markets, and prepare for a Series A round by the end of 2024.
“We are thrilled to be a part of inHEART’s journey in transforming cardiac arrhythmia treatment and cardiovascular prevention”, says Milen Ivanov, Managing Partner at Sofia Angels Ventures. “It is rare opportunity to be an investor in such an IP-rich company that has the potential to revolutionize the way we address cardiac health challenges. We believe that inHEART’s visionary team and groundbreaking technology will make a significant impact on patient outcomes and contribute to advancing the field of digital health.”
The partnership between SAV and inHEART highlights the shared commitment to fostering innovation and driving positive change in the healthcare industry. Through its strategic investments, SAV continues to support cutting-edge startups that exhibit tremendous potential for growth and global impact.
“We are honoured to have Sofia Angels Ventures as a key partner in this phase of inHEART’s growth.” said Todor Jeliaskov, CEO of inHEART. “Their expertise in financing and rigorous decision-making approach, coupled with their vast network of resources, will undoubtedly contribute to our mission of making treatment and prevention of patients with cardiac diseases more precise, efficient, and accessible. We are confident inHEART is well-positioned to achieve new heights.”